Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;24(2):e80-e81.
doi: 10.1016/S1473-3099(23)00779-X. Epub 2024 Jan 5.

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden

Ulrika Marking  1 , Oscar Bladh  2 , Katherina Aguilera  2 , Yiqiu Yang  3 , Nina Greilert Norin  2 , Kim Blom  1 , Sophia Hober  4 , Jonas Klingström  5 , Sebastian Havervall  4 , Mikael Åberg  6 , Daniel J Sheward  3 , Charlotte Thålin  7
Affiliations

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden

Ulrika Marking et al. Lancet Infect Dis. 2024 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

pCMV-dR8·2 dvpr was a gift from Bob Weinberg (Addgene plasmid # 8455; http://n2t.net/addgene:8455; RRID:Addgene_8455). pBOBI-FLuc was a gift from David Nemazee (Addgene plasmid # 170674; http://n2t.net/addgene:170674; RRID: Addgene_170674). We acknowledge the G2P-UK National Virology consortium funded by MRC/UKRI (grant ref: MR/W005611/1) and the Barclay Lab at Imperial College for providing the XBB.1.5 spike plasmid. We gratefully acknowledge all data contributors, ie, the authors and their originating laboratories responsible for obtaining the specimens, and their submitting laboratories that generated the genetic sequence and metadata and shared via the GISAID Initiative the data on which part of this research is based. This project was supported by funding from the Jonas and Christina af Jochnick Foundation, Region Stockholm, SciLifeLab/Knut and Alice Wallenberg Foundation, SciLifeLab's Pandemic Laboratory Preparedness program (VC-2022–0028) and from the Erling Persson Foundation (2021 0125). DJS has served as a consultant for AstraZeneca outside this comment. All other authors declare no competing interests. UM and OB contributed equally and share first authorship; DJS and CT jointly supervised the work and share last authorship.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

LinkOut - more resources